跳转至内容
Merck
  • Histamine in the locus coeruleus promotes descending noradrenergic inhibition of neuropathic hypersensitivity.

Histamine in the locus coeruleus promotes descending noradrenergic inhibition of neuropathic hypersensitivity.

Pharmacological research (2014-10-12)
Hong Wei, Cong-Yu Jin, Hanna Viisanen, Hao-Jun You, Antti Pertovaara
摘要

Among brain structures receiving efferent projections from the histaminergic tuberomammillary nucleus is the pontine locus coeruleus (LC) involved in descending noradrenergic control of pain. Here we studied whether histamine in the LC is involved in descending regulation of neuropathic hypersensitivity. Peripheral neuropathy was induced by unilateral spinal nerve ligation in the rat with a chronic intracerebral and intrathecal catheter for drug administrations. Mechanical hypersensitivity in the injured limb was assessed by monofilaments. Heat nociception was assessed by determining radiant heat-induced paw flick. Histamine in the LC produced a dose-related (1-10μg) mechanical antihypersensitivity effect (maximum effect at 15min and duration of effect 30min), without influence on heat nociception. Pretreatment of LC with zolantidine (histamine H2 receptor antagonist), but not with pyrilamine (histamine H1 receptor antagonist), and spinal administration of atipamezole (an α2-adrenoceptor antagonist), prazosine (an α1-adrenoceptor antagonist) or bicuculline (a GABAA receptor antagonist) attenuated the antihypersensitivity effect of histamine. The histamine-induced antihypersensitivity effect was also reduced by pretreatment of LC with fadolmidine, an α2-adrenoceptor agonist inducing autoinhibition of noradrenergic cell bodies. Zolantidine or pyrilamine alone in the LC failed to influence pain behavior, while A-960656 (histamine H3 receptor antagonist) suppressed hypersensitivity. A plausible explanation for these findings is that histamine, due to excitatory action mediated by the histamine H2 receptor on noradrenergic cell bodies, promotes descending spinal α1/2-adrenoceptor-mediated inhibition of neuropathic hypersensitivity. Blocking the autoinhibitory histamine H3 receptor on histaminergic nerve terminals in the LC facilitates release of histamine and thereby, increases descending noradrenergic pain inhibition.

材料
货号
品牌
产品描述

Sigma-Aldrich
利多卡因, powder
Sigma-Aldrich
L-赖氨酸 单盐酸盐, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
组胺 二盐酸盐, ≥99% (TLC), powder
Sigma-Aldrich
组胺, ≥97.0%
USP
利多卡因, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
组胺 二盐酸盐, ≥99.0% (AT)
Sigma-Aldrich
L-赖氨酸 单盐酸盐, reagent grade, ≥98% (HPLC)
Supelco
利多卡因, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
西咪替丁
Sigma-Aldrich
利多卡因, analytical standard
Supelco
组胺, analytical standard
Sigma-Aldrich
吡拉明 马来酸盐
Sigma-Aldrich
(+)-荷包牡丹碱, ≥97.0% (TLC)
Supelco
L-赖氨酸 单盐酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-赖氨酸 单盐酸盐, BioUltra, ≥99.5% (AT)
USP
西咪替丁, United States Pharmacopeia (USP) Reference Standard
赖氨酸 盐酸盐, European Pharmacopoeia (EP) Reference Standard
Supelco
L-赖氨酸盐酸盐 溶液, 100 mM amino acid in 0.1 M HCl, analytical standard
Supelco
西咪替丁, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-赖氨酸 单盐酸盐, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
利多卡因, European Pharmacopoeia (EP) Reference Standard
Supelco
吡拉明马来酸, Pharmaceutical Secondary Standard; Certified Reference Material
组胺 二盐酸盐, European Pharmacopoeia (EP) Reference Standard
吡拉明 马来酸盐, European Pharmacopoeia (EP) Reference Standard
西咪替丁, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-赖氨酸 单盐酸盐, SAJ special grade, ≥99.0%
西咪替丁, European Pharmacopoeia (EP) Reference Standard
西咪替丁, European Pharmacopoeia (EP) Reference Standard